dc.contributor.author | Hepburn, LA | en_US |
dc.contributor.author | McHugh, A | en_US |
dc.contributor.author | Fernandes, K | en_US |
dc.contributor.author | Boag, G | en_US |
dc.contributor.author | Proby, CM | en_US |
dc.contributor.author | Leigh, IM | en_US |
dc.contributor.author | Saville, MK | en_US |
dc.date.accessioned | 2018-11-19T14:48:26Z | |
dc.date.issued | 2018-05-01 | en_US |
dc.date.submitted | 2018-11-08T16:17:55.772Z | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/51785 | |
dc.description.sponsorship | This study was supported by DEBRA International and funded by DEBRA Austria (Saville-Proby 1). I.M.L and M.K.S were supported by an ERC Advanced Investigator Award (250170, Principal Investigator I.M.L.). C.M.P. and I.M.L. were supported by a Cancer Research UK Programme Grant (A13044). | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Oncotarget | en_US |
dc.rights | This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
dc.title | Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity | en_US |
dc.type | Article | |
dc.rights.holder | Copyright: Hepburn et al. | |
dc.identifier.doi | 10.18632/oncotarget.25196 | en_US |
pubs.issue | 33 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 9 | en_US |